Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/44961, first published .
Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Beatriz Grinsztejn   1 , MD, PhD ;   Thiago Silva Torres   1 , PhD ;   Brenda Hoagland   1 , MD, PhD ;   Emilia Moreira Jalil   1 , MD, PhD ;   Ronaldo Ismerio Moreira   1 , PhD ;   Gabrielle O'Malley   2 , PhD ;   Starley B Shade   3 , PhD ;   Marcos R Benedetti   1 , MSc ;   Julio Moreira   4 , BA ;   Keila Simpson   5 , BA ;   Maria Cristina Pimenta   6 , PhD ;   Valdiléa Gonçalves Veloso   1 , MD, PhD ;   The ImPrEP CAB-Brasil Study Team   7

1 Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

2 Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, WA, United States

3 Institute for Global Health Sciences, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States

4 Grupo Arco-Íris de Cidadania LGBT, Rio de Janeiro, Brazil

5 Associação Nacional de Travestis e Transexuais, Salvador, Brazil

6 Brazilian Ministry of Health, Brasilia, Brazil

7 See Acknowledgements, Rio de Janeiro, Brazil

Corresponding Author:

  • Beatriz Grinsztejn, MD, PhD
  • Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz
  • Av. Brasil 4365 Manguinhos
  • Rio de Janeiro, 21040360
  • Brazil
  • Phone: 55 21 38659128
  • Email: gbeatriz@ini.fiocruz.br